A Comparative Study of Mometasone Furoate Nasal Spray & Fluticasone

See also
Status	Clinical Trial	Phase
Completed	`NCT01654536` - A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)	Phase 4
Completed	`NCT01221285` - Development of Cockroach Immunotherapy by the Inner-City Asthma Consortium	Phase 1
Completed	`NCT01539304` - Clinical Trial to Evaluate the Safety and Efficacy of "CITUS Dry Syrup" in Children With Perennial Allergic Rhinitis	Phase 3
Terminated	`NCT00491374` - Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)	Phase 4
Completed	`NCT04324918` - Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis	Phase 3
Completed	`NCT02532179` - Subcutaneous Immunotherapy for Mouse in Adults	Phase 1/Phase 2
Completed	`NCT01451541` - A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).	Phase 3
Enrolling by invitation	`NCT01062139` - Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy	Phase 4
Completed	`NCT00405899` - Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections	N/A
Completed	`NCT01549340` - Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)	N/A
Completed	`NCT01018862` - A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis	Phase 3
Completed	`NCT00789555` - Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis	Phase 4
Completed	`NCT00261287` - Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)	Phase 3
Completed	`NCT00974571` - Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)	Phase 3
Completed	`NCT04654702` - Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.
Completed	`NCT05122143` - Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers	N/A
Completed	`NCT01380327` - Biomarkers of Cockroach Sublingual Immunotherapy 2	Phase 1/Phase 2
Completed	`NCT01116778` - the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis	Phase 3
Completed	`NCT00359216` - The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)	Phase 4
Completed	`NCT01127620` - Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension	Phase 3

NCT number	NCT00783224
Study type	Interventional
Source	Organon and Co
Contact
Status	Completed
Phase	Phase 3
Start date	September 2005
Completion date	December 2005

A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms